These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4841023)

  • 1. Doxorubicin in combination chemotherapy for breast cancer: a preliminary report.
    Ward HW
    Br J Clin Pract; 1974 Apr; 28(4):137-8. PubMed ID: 4841023
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of breast cancer. Investigational treatment.
    Jones SE
    Ariz Med; 1974 Mar; 31(3):197-8. PubMed ID: 4362033
    [No Abstract]   [Full Text] [Related]  

  • 3. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
    Minisini AM; Andreetta C; Fasola G; Puglisi F
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome.
    Ibrahim NK; Frye DK; Buzdar AU; Walters RS; Hortobagyi GN
    Arch Intern Med; 1996 Apr; 156(8):882-8. PubMed ID: 8774207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy in breast neoplasms. A review].
    Pedersen H; Larsen V
    Ugeskr Laeger; 1976 Jun; 138(24):1445-9. PubMed ID: 1273972
    [No Abstract]   [Full Text] [Related]  

  • 7. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New 2004 guidelines of the Breast Organ Committee of AGO].
    Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
    [No Abstract]   [Full Text] [Related]  

  • 9. Docetaxel: new preparation. No first-line use in metastatic breast cancer.
    Prescrire Int; 2001 Dec; 10(56):178-9. PubMed ID: 11824441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisantrene, an active new drug in the treatment of metastatic breast cancer.
    Yap HY; Yap BS; Blumenschein GR; Barnes BC; Schell FC; Bodey GP
    Cancer Res; 1983 Mar; 43(3):1402-4. PubMed ID: 6825109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
    Campora E; Nobile MT; Sertoli MR; Rosso R
    Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
    Jones WG; Mattsson W
    Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local radiotherapy and adriblastin chemotherapy in metastatic breast carcinoma].
    Renner H; Zeinz M
    Strahlentherapie Sonderb; 1978; 75():199-201. PubMed ID: 95495
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide, prednisone, staphage lysate and warfarin in disseminated breast cancer.
    D'Souza DP; Daly L; Thornes RD
    Ir Med J; 1980 Oct; 73(10):385-7. PubMed ID: 7429789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA
    Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
    [No Abstract]   [Full Text] [Related]  

  • 19. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

  • 20. Doxorubicin/paclitaxel combination chemotherapy for metastatic breast cancer: the Eastern Cooperative Oncology Group experience.
    Sledge GW
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):123-5; discussion 126-9. PubMed ID: 7481854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.